Association Between Long-term Quinine Exposure and All-Cause Mortality
- PMID: 28492890
- PMCID: PMC5815033
- DOI: 10.1001/jama.2017.2332
Association Between Long-term Quinine Exposure and All-Cause Mortality
Abstract
This cohort study uses UK primary care database data to explore the association between long-term quinine exposure and all-cause mortality.
Conflict of interest statement
Similar articles
-
A simple alternative to quinine for nocturnal muscle cramps.Md Med J. 1996 May;45(5):383. Md Med J. 1996. PMID: 8935851 No abstract available.
-
Photoallergic reaction to systemic quinine sulphate.Contact Dermatitis. 2007 Dec;57(6):384-6. doi: 10.1111/j.0105-1873.2006.00808.x. Contact Dermatitis. 2007. PMID: 17988291 No abstract available.
-
Quinine and cramp: uncertainty efficacy, major risks.Prescrire Int. 2000 Oct;9(49):154-7. Prescrire Int. 2000. PMID: 11603417 Review.
-
Quinine for cramps.Aust Fam Physician. 1998 Oct;27(10):922-3. Aust Fam Physician. 1998. PMID: 9798291
-
Quinine-induced hemolytic uremic syndrome.Clin Nephrol. 1997 Jun;47(6):397-400. Clin Nephrol. 1997. PMID: 9202872 Review.
Cited by
-
Quinine exposure and the risk of acute kidney injury: a population-based observational study of older people.Age Ageing. 2020 Oct 23;49(6):1042-1047. doi: 10.1093/ageing/afaa079. Age Ageing. 2020. PMID: 32463438 Free PMC article.
-
Quinine Use and the Risk of Exacerbations of Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Registry Study.Int J Chron Obstruct Pulmon Dis. 2025 May 21;20:1585-1593. doi: 10.2147/COPD.S496676. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40417410 Free PMC article.
-
Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.J Autism Dev Disord. 2020 Feb;50(2):625-633. doi: 10.1007/s10803-019-04291-8. J Autism Dev Disord. 2020. PMID: 31724119 Free PMC article.
-
The Fever Tree: from Malaria to Neurological Diseases.Toxins (Basel). 2018 Nov 23;10(12):491. doi: 10.3390/toxins10120491. Toxins (Basel). 2018. PMID: 30477182 Free PMC article. Review.
-
Quinine inhibits myogenic differentiation by disrupting AKT signaling pathway.Toxicol Res. 2024 Dec 13;41(1):81-90. doi: 10.1007/s43188-024-00273-w. eCollection 2025 Jan. Toxicol Res. 2024. PMID: 39802114
References
-
- US Food and Drug Administration, Dept of Health and Human Services . Drug products containing quinine; enforcement action dates. https://www.fda.gov/OHRMS/DOCKETS/98fr/06-9713.htm. Accessed March 22, 2017.
-
- Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251-255. - PubMed
-
- Feas X, Brasic JR, Fente CA, Cepada A. La quinina y sus posibles implicaciones toxicológicas: análysis de aguas tónicas en España [in Spanish]. Rev Esp Nutr Comunitaria. 2009;15:97-102.
-
- Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990;82(4):1106-1116. - PubMed
-
- Katzberg HD, Khan AH, So YT. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology. 2010;74(8):691-696. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical